Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Cipro
|
| gptkbp:appointed_by |
injection
intravenous route oral route oral tablet |
| gptkbp:caused_by |
arrhythmias at high levels
gastrointestinal disturbances at high levels toxicity at high levels |
| gptkbp:composed_of |
gptkb:xanthine
|
| gptkbp:contraindication |
peptic ulcer disease
hyperthyroidism seizure disorders |
| gptkbp:developed_by |
cocoa beans
tea leaves |
| gptkbp:has_influence_on |
gptkb:superhero
|
| https://www.w3.org/2000/01/rdf-schema#label |
theophylline
|
| gptkbp:ingredients |
C7 H8 N4 O2
|
| gptkbp:is_analyzed_in |
cardiovascular diseases
respiratory diseases |
| gptkbp:is_available_in |
liquid form
extended-release form |
| gptkbp:is_available_on |
generic medication
brand name medication |
| gptkbp:is_known_for |
its historical use in medicine
narrow therapeutic index its role in respiratory therapy |
| gptkbp:is_part_of |
combination therapy
long-term management of asthma asthma action plans pulmonary rehabilitation programs COPD action plans clinical guidelines for COPD clinical guidelines for asthma emergency treatment for asthma long-term management of COPD treatment regimen for COPD treatment regimen for asthma |
| gptkbp:is_related_to |
theobromine
caffeine |
| gptkbp:is_studied_in |
potential anti-inflammatory effects
potential neuroprotective effects |
| gptkbp:is_used_for |
gptkb:asthma
COPD |
| gptkbp:is_used_in |
sports medicine
pediatric medicine adult medicine critical care medicine |
| gptkbp:is_used_to |
improve airflow
relieve symptoms of bronchospasm |
| gptkbp:lifespan |
8 hours
|
| gptkbp:metabolism |
liver
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:relationship |
gptkb:cimetidine
oral contraceptives certain antibiotics |
| gptkbp:scientific_classification |
xanthine derivative
|
| gptkbp:side_effect |
nausea
insomnia increased heart rate |
| gptkbp:weight |
180.17 g/mol
|